Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1

Anne M. Slavotinek, Pavni Mehrotra, Irina Nazarenko, Paul Ling Fung Tang, Richard Lao, Don Cameron, Ben Li, Catherine Chu, Chris Chou, Ann L. Marqueling, Mani Yahyavi, Kelly Cordoro, Ilona Frieden, Thomas M Glaser, Trine Prescott, Marie Anne Morren, Koen Devriendt, Pui Yan Kwok, Martin Petkovich, Robert J. Desnick

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Focal facial dermal dysplasia (FFDD) Type IV is a rare syndrome characterized by facial lesions resembling aplasia cutis in a preauricular distribution along the line of fusion of the maxillary and mandibular prominences. To identify the causative gene(s), exome sequencing was performed in a family with two affected siblings. Assuming autosomal recessive inheritance, two novel sequence variants were identified in both siblings in CYP26C1-a duplication of seven base pairs, which was maternally inherited, c.844_851dupCCATGCA, predicting p.Glu284fsX128 and a missense mutation, c.1433G>A, predicting p.Arg478His, that was paternally inherited. The duplication predicted a frameshift mutation that led to a premature stop codon and premature chain termination, whereas the missense mutation was not functional based on its in vitro expression in mammalian cells. The FFDD skin lesions arise along the sites of fusion of the maxillary and mandibular prominences early in facial development, and Cyp26c1 was expressed exactly along the fusion line for these facial prominences in the first branchial arch in mice. Sequencing of four additional, unrelated Type IV FFDD patients and eight Type II or III TWIST2-negative FFDD patients revealed that three of the Type IV patients were homozygous for the duplication, whereas none of the Type II or III patients had CYP26C1 mutations. The seven base pairs duplication was present in 0.3% of healthy controls and 0.3% of patients with other birth defects. These findings suggest that the phenotypic manifestations of FFDD Type IV can be non-penetrant or underascertained. Thus, FFDD Type IV results from the loss of function mutations in CYP26C1.

Original languageEnglish (US)
Article numberdds477
Pages (from-to)696-703
Number of pages8
JournalHuman Molecular Genetics
Volume22
Issue number4
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Mutation
Missense Mutation
Base Pairing
Siblings
Exome
Branchial Region
Frameshift Mutation
Nonsense Codon
Focal facial dermal dysplasia
Skin
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Slavotinek, A. M., Mehrotra, P., Nazarenko, I., Tang, P. L. F., Lao, R., Cameron, D., ... Desnick, R. J. (2013). Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. Human Molecular Genetics, 22(4), 696-703. [dds477]. https://doi.org/10.1093/hmg/dds477

Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. / Slavotinek, Anne M.; Mehrotra, Pavni; Nazarenko, Irina; Tang, Paul Ling Fung; Lao, Richard; Cameron, Don; Li, Ben; Chu, Catherine; Chou, Chris; Marqueling, Ann L.; Yahyavi, Mani; Cordoro, Kelly; Frieden, Ilona; Glaser, Thomas M; Prescott, Trine; Morren, Marie Anne; Devriendt, Koen; Kwok, Pui Yan; Petkovich, Martin; Desnick, Robert J.

In: Human Molecular Genetics, Vol. 22, No. 4, dds477, 02.2013, p. 696-703.

Research output: Contribution to journalArticle

Slavotinek, AM, Mehrotra, P, Nazarenko, I, Tang, PLF, Lao, R, Cameron, D, Li, B, Chu, C, Chou, C, Marqueling, AL, Yahyavi, M, Cordoro, K, Frieden, I, Glaser, TM, Prescott, T, Morren, MA, Devriendt, K, Kwok, PY, Petkovich, M & Desnick, RJ 2013, 'Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1', Human Molecular Genetics, vol. 22, no. 4, dds477, pp. 696-703. https://doi.org/10.1093/hmg/dds477
Slavotinek AM, Mehrotra P, Nazarenko I, Tang PLF, Lao R, Cameron D et al. Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. Human Molecular Genetics. 2013 Feb;22(4):696-703. dds477. https://doi.org/10.1093/hmg/dds477
Slavotinek, Anne M. ; Mehrotra, Pavni ; Nazarenko, Irina ; Tang, Paul Ling Fung ; Lao, Richard ; Cameron, Don ; Li, Ben ; Chu, Catherine ; Chou, Chris ; Marqueling, Ann L. ; Yahyavi, Mani ; Cordoro, Kelly ; Frieden, Ilona ; Glaser, Thomas M ; Prescott, Trine ; Morren, Marie Anne ; Devriendt, Koen ; Kwok, Pui Yan ; Petkovich, Martin ; Desnick, Robert J. / Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. In: Human Molecular Genetics. 2013 ; Vol. 22, No. 4. pp. 696-703.
@article{b4f7ab3c473a47bea38169e950d532e9,
title = "Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1",
abstract = "Focal facial dermal dysplasia (FFDD) Type IV is a rare syndrome characterized by facial lesions resembling aplasia cutis in a preauricular distribution along the line of fusion of the maxillary and mandibular prominences. To identify the causative gene(s), exome sequencing was performed in a family with two affected siblings. Assuming autosomal recessive inheritance, two novel sequence variants were identified in both siblings in CYP26C1-a duplication of seven base pairs, which was maternally inherited, c.844_851dupCCATGCA, predicting p.Glu284fsX128 and a missense mutation, c.1433G>A, predicting p.Arg478His, that was paternally inherited. The duplication predicted a frameshift mutation that led to a premature stop codon and premature chain termination, whereas the missense mutation was not functional based on its in vitro expression in mammalian cells. The FFDD skin lesions arise along the sites of fusion of the maxillary and mandibular prominences early in facial development, and Cyp26c1 was expressed exactly along the fusion line for these facial prominences in the first branchial arch in mice. Sequencing of four additional, unrelated Type IV FFDD patients and eight Type II or III TWIST2-negative FFDD patients revealed that three of the Type IV patients were homozygous for the duplication, whereas none of the Type II or III patients had CYP26C1 mutations. The seven base pairs duplication was present in 0.3{\%} of healthy controls and 0.3{\%} of patients with other birth defects. These findings suggest that the phenotypic manifestations of FFDD Type IV can be non-penetrant or underascertained. Thus, FFDD Type IV results from the loss of function mutations in CYP26C1.",
author = "Slavotinek, {Anne M.} and Pavni Mehrotra and Irina Nazarenko and Tang, {Paul Ling Fung} and Richard Lao and Don Cameron and Ben Li and Catherine Chu and Chris Chou and Marqueling, {Ann L.} and Mani Yahyavi and Kelly Cordoro and Ilona Frieden and Glaser, {Thomas M} and Trine Prescott and Morren, {Marie Anne} and Koen Devriendt and Kwok, {Pui Yan} and Martin Petkovich and Desnick, {Robert J.}",
year = "2013",
month = "2",
doi = "10.1093/hmg/dds477",
language = "English (US)",
volume = "22",
pages = "696--703",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1

AU - Slavotinek, Anne M.

AU - Mehrotra, Pavni

AU - Nazarenko, Irina

AU - Tang, Paul Ling Fung

AU - Lao, Richard

AU - Cameron, Don

AU - Li, Ben

AU - Chu, Catherine

AU - Chou, Chris

AU - Marqueling, Ann L.

AU - Yahyavi, Mani

AU - Cordoro, Kelly

AU - Frieden, Ilona

AU - Glaser, Thomas M

AU - Prescott, Trine

AU - Morren, Marie Anne

AU - Devriendt, Koen

AU - Kwok, Pui Yan

AU - Petkovich, Martin

AU - Desnick, Robert J.

PY - 2013/2

Y1 - 2013/2

N2 - Focal facial dermal dysplasia (FFDD) Type IV is a rare syndrome characterized by facial lesions resembling aplasia cutis in a preauricular distribution along the line of fusion of the maxillary and mandibular prominences. To identify the causative gene(s), exome sequencing was performed in a family with two affected siblings. Assuming autosomal recessive inheritance, two novel sequence variants were identified in both siblings in CYP26C1-a duplication of seven base pairs, which was maternally inherited, c.844_851dupCCATGCA, predicting p.Glu284fsX128 and a missense mutation, c.1433G>A, predicting p.Arg478His, that was paternally inherited. The duplication predicted a frameshift mutation that led to a premature stop codon and premature chain termination, whereas the missense mutation was not functional based on its in vitro expression in mammalian cells. The FFDD skin lesions arise along the sites of fusion of the maxillary and mandibular prominences early in facial development, and Cyp26c1 was expressed exactly along the fusion line for these facial prominences in the first branchial arch in mice. Sequencing of four additional, unrelated Type IV FFDD patients and eight Type II or III TWIST2-negative FFDD patients revealed that three of the Type IV patients were homozygous for the duplication, whereas none of the Type II or III patients had CYP26C1 mutations. The seven base pairs duplication was present in 0.3% of healthy controls and 0.3% of patients with other birth defects. These findings suggest that the phenotypic manifestations of FFDD Type IV can be non-penetrant or underascertained. Thus, FFDD Type IV results from the loss of function mutations in CYP26C1.

AB - Focal facial dermal dysplasia (FFDD) Type IV is a rare syndrome characterized by facial lesions resembling aplasia cutis in a preauricular distribution along the line of fusion of the maxillary and mandibular prominences. To identify the causative gene(s), exome sequencing was performed in a family with two affected siblings. Assuming autosomal recessive inheritance, two novel sequence variants were identified in both siblings in CYP26C1-a duplication of seven base pairs, which was maternally inherited, c.844_851dupCCATGCA, predicting p.Glu284fsX128 and a missense mutation, c.1433G>A, predicting p.Arg478His, that was paternally inherited. The duplication predicted a frameshift mutation that led to a premature stop codon and premature chain termination, whereas the missense mutation was not functional based on its in vitro expression in mammalian cells. The FFDD skin lesions arise along the sites of fusion of the maxillary and mandibular prominences early in facial development, and Cyp26c1 was expressed exactly along the fusion line for these facial prominences in the first branchial arch in mice. Sequencing of four additional, unrelated Type IV FFDD patients and eight Type II or III TWIST2-negative FFDD patients revealed that three of the Type IV patients were homozygous for the duplication, whereas none of the Type II or III patients had CYP26C1 mutations. The seven base pairs duplication was present in 0.3% of healthy controls and 0.3% of patients with other birth defects. These findings suggest that the phenotypic manifestations of FFDD Type IV can be non-penetrant or underascertained. Thus, FFDD Type IV results from the loss of function mutations in CYP26C1.

UR - http://www.scopus.com/inward/record.url?scp=84873049034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873049034&partnerID=8YFLogxK

U2 - 10.1093/hmg/dds477

DO - 10.1093/hmg/dds477

M3 - Article

C2 - 23161670

AN - SCOPUS:84873049034

VL - 22

SP - 696

EP - 703

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 4

M1 - dds477

ER -